Yuriy Shostak, Ph.D. - Publications

Institution:
University of California, San Francisco, San Francisco, CA
Area:
glucocorticoid transcription

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Chiuppesi F, Salazar MD, Contreras H, Nguyen VH, Martinez J, Park Y, Nguyen J, Kha M, Iniguez A, Zhou Q, Kaltcheva T, Levytskyy R, Ebelt ND, Kang TH, Wu X, ... ... Shostak Y, et al. Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform. Nature Communications. 11: 6121. PMID 33257686 DOI: 10.1038/s41467-020-19819-1  1
2020 Chiuppesi F, Salazar MDA, Contreras H, Nguyen V, Martinez J, Park S, Nguyen J, Kha M, Iniguez A, Zhou Q, Kaltcheva T, Levytskyy R, Ebelt N, Kang T, Wu X, ... ... Shostak Y, et al. Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform. Research Square. PMID 32702732 DOI: 10.21203/rs.3.rs-40198/v1  1
2020 Chiuppesi F, Salazar MD, Contreras H, Nguyen VH, Martinez J, Park S, Nguyen J, Kha M, Iniguez A, Zhou Q, Kaltcheva T, Levytskyy R, Ebelt ND, Kang TH, Wu X, ... ... Shostak Y, et al. Development of a Synthetic Poxvirus-Based SARS-CoV-2 Vaccine. Biorxiv : the Preprint Server For Biology. PMID 32637957 DOI: 10.1101/2020.07.01.183236  1
2016 Challita-Eid PM, Satpayev D, Yang P, An Z, Morrison K, Shostak Y, Raitano A, Nadell R, Liu W, Lortie DR, Capo L, Verlinsky A, Leavitt M, Malik F, Avina H, et al. Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models. Cancer Research. PMID 27013195 DOI: 10.1158/0008-5472.CAN-15-1313  1
2015 Donate F, Raitano A, Morrison K, An Z, Capo L, Avina H, Karki S, Morrison K, Yang P, Ou J, Moriya R, Shostak Y, Malik F, Nadell R, Liu W, et al. AGS16F is a Novel Antibody Drug Conjugate Directed Against ENPP3 for the Treatment of Renal Cell Carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26589436 DOI: 10.1158/1078-0432.Ccr-15-1542  1
2013 Mattie M, Christensen A, Chang MS, Yeh W, Said S, Shostak Y, Capo L, Verlinsky A, An Z, Joseph I, Zhang Y, Kumar-Ganesan S, Morrison K, Stover D, Challita-Eid P. Molecular characterization of patient-derived human pancreatic tumor xenograft models for preclinical and translational development of cancer therapeutics. Neoplasia (New York, N.Y.). 15: 1138-50. PMID 24204193 DOI: 10.1593/neo.13922  1
2005 Shostak Y, Yamamoto KR. Overlapping but separable determinants of DNA binding and nuclear localization map to the C-terminal end of the Caenorhabditis elegans DAF-12 DNA binding domain. The Journal of Biological Chemistry. 280: 6554-60. PMID 15611047 DOI: 10.1074/Jbc.M412928200  1
2004 Shostak Y, Van Gilst MR, Antebi A, Yamamoto KR. Identification of C. elegans DAF-12-binding sites, response elements, and target genes. Genes & Development. 18: 2529-44. PMID 15489294 DOI: 10.1101/Gad.1218504  1
1999 Huang W, Shostak Y, Tarr P, Sawyers C, Carey M. Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate-specific antigen enhancer. The Journal of Biological Chemistry. 274: 25756-68. PMID 10464314 DOI: 10.1074/Jbc.274.36.25756  1
1999 Craft N, Shostak Y, Carey M, Sawyers CL. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. Nature Medicine. 5: 280-5. PMID 10086382 DOI: 10.1038/6495  1
Show low-probability matches.